Lazard Asset Management
INSP icon

Lazard Asset Management’s Inspire Medical Systems INSP Stock Holding History

Lazard Asset Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$974K Buy
21,840
+2,902
+15% +$138K ﹤0.01% 1235
2026
Q1 		$977K Sell
18,938
-26,043
-58% -$1.82M ﹤0.01% 1176
2025
Q4 		$4.15M Sell
44,981
-44,624
-50% -$4.27M 0.01% 610
2025
Q3 		$6.65M Buy
89,605
+17,500
+24% +$1.77M 0.01% 502
2025
Q2 		$9.36M Buy
72,105
+16,536
+30% +$2.4M 0.01% 565
2025
Q1 		$8.85M Sell
55,569
-8,713
-14% -$1.58M 0.01% 518
2024
Q4 		$11.9M Sell
64,282
-922
-1% -$179K 0.02% 432
2024
Q3 		$13.8M Sell
65,204
-36,639
-36% -$6.36M 0.02% 403
2024
Q2 		$13.6M Buy
101,843
+38,647
+61% +$7.31M 0.02% 456
2024
Q1 		$13.6M Buy
63,196
+29,039
+85% +$5.69M 0.02% 463
2023
Q4 		$6.95M Sell
34,157
-3,418
-9% -$554K 0.01% 627
2023
Q3 		$7.46M Buy
37,575
+3,522
+10% +$888K 0.01% 618
2023
Q2 		$11.1M Sell
34,053
-3,731
-10% -$1.07M 0.01% 537
2023
Q1 		$8.84M Buy
37,784
+473
+1% +$120K 0.01% 609
2022
Q4 		$9.4M Sell
37,311
-48,243
-56% -$10.3M 0.01% 588
2022
Q3 		$15.2M Buy
85,554
+4,621
+6% +$929K 0.02% 484
2022
Q2 		$14.8M Buy
80,933
+28,060
+53% +$5.6M 0.02% 510
2022
Q1 		$13.6M Buy
52,873
+12,608
+31% +$2.88M 0.02% 551
2021
Q4 		$9.26M Buy
40,265
+15,328
+61% +$3.74M 0.01% 652
2021
Q3 		$5.81M Sell
24,937
-2,038
-8% -$425K 0.01% 724
2021
Q2 		$5.21M Buy
26,975
+26,605
+7,191% +$5.28M 0.01% 721
2021
Q1 		$76K Sell
370
-44
-11% -$9.35K ﹤0.01% 1274
2020
Q4 		$77K Buy
+414
New +$67.7K ﹤0.01% 1247
2020
Q2 		– Sell
-905
Closed -$54K – 1695
2020
Q1 		$54K Buy
+905
New +$67K ﹤0.01% 1146

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lazard Asset Management's INSP Position: Q2 2026 in Review

Lazard Asset Management increased its Inspire Medical Systems (INSP) stake by 15% in Q2 2026, buying an estimated $138K and bringing the position to 21,840 shares worth $974K. The position accounts for ﹤0.01% of the portfolio, ranked #1235.

Lazard Asset Management first reported a position in INSP in Q1 2020 and has held it in 24 quarters since. The position peaked at $15.2M in Q3 2022. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Lazard Asset Management held 21,840 shares of Inspire Medical Systems worth $974K as of Q2 2026.
  • Lazard Asset Management bought 2,902 Inspire Medical Systems shares in Q2 2026, an estimated $138K.
  • Inspire Medical Systems made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1235 holding.
  • Lazard Asset Management first reported a position in Inspire Medical Systems in Q1 2020 and has held it in 24 quarters since.
  • Lazard Asset Management's Inspire Medical Systems position peaked at $15.2M in Q3 2022.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.